Smoking Cessation in COPD Causes a Transient Improvement in Spirometry and Decreases Micronodules on High-resolution CT Imaging

Overview

Journal Chest

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2014 Feb 14

PMID 24522562

Citations 13

Authors

Jaideep Dhariwal

Rachel C Tennant

David M Hansell

John Westwick

Christoph Walker

Simon P Ward

Neil Pride

Peter J Barnes

Onn Min Kon

Trevor T Hansel

Affiliations

Soon will be listed here.

Abstract

Background: Smoking cessation is of major importance for all smokers; however, in patients with COPD, little information exists on how smoking cessation influences lung function and high-resolution CT (HRCT) scan appearances.

Methods: In this single-center study, we performed screening spirometry in a group of heavy smokers aged 40 to 80 years (N = 358). We then studied the effects of smoking cessation in two groups of selected subjects: smokers with COPD (n = 38) and smokers with normal spirometry (n = 55). In parallel to subjects undergoing smoking cessation, we studied a control group of nonsmokers (n = 19).

Results: Subjects with COPD who quit smoking had a marked, but transient improvement in FEV1 at 6 weeks (184 mL, n = 17, P < .01) that was still present at 12 weeks (81 mL, n = 17, P < .05) and only partially maintained at 1 year. In contrast, we saw improvement in the transfer factor of lung for carbon monoxide at 6 weeks in both subjects with COPD who quit smoking (0.47 mmol/min/kPa, n = 17, P < .01) and subjects who quit smoking with normal spirometry (0.40 mmol/min/kPa, n = 35, P < .01). An upper-zone single HRCT image slice reliably identified emphysema at baseline in 74% of smokers with COPD (28 of 38) and 29% of healthy smokers (16 of 55). Smoking cessation had no significant effect on the appearances of emphysema but decreased the presence of micronodules on HRCT imaging.

Conclusions: Cigarette smoking causes extensive lung function and HRCT image abnormalities, even in patients with normal spirometry. Smoking cessation has differential effects on lung function (FEV1 and gas transfer) and features on HRCT images (emphysema and micronodules). Cessation of smoking in patients with COPD causes a transient improvement in FEV1 and decreases the presence of micronodules, offering an opportunity for concomitant therapy during smoking cessation to augment these effects. Smoking cessation at the earliest possible opportunity is vital to minimize permanent damage to the lungs.

Citing Articles

Impact of electronic cigarette usage on the onset of respiratory symptoms and COPD among Chinese adults.

Song B, Li H, Zhang H, Jiao L, Wu S Sci Rep. 2024; 14(1):5598.

PMID: 38454045 PMC: 10920732. DOI: 10.1038/s41598-024-56368-9.

Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations.

Miravitlles M, Bhutani M, Hurst J, Franssen F, van Boven J, Khoo E Adv Ther. 2023; 40(10):4236-4263.

PMID: 37537515 PMC: 10499689. DOI: 10.1007/s12325-023-02609-8.

Association between smoking cessation and alterations in forced expiratory volume in one second (FEV1). A Follow-Up Study from a Greek Tobacco Cessation Clinic.

Trakas N, Georgakopoulou V, Melemeni D, Damaskos C, Mantzouranis K, Garmpis N Addict Health. 2022; 14(2):87-95.

PMID: 36544517 PMC: 9743813. DOI: 10.22122/AHJ.2022.196722.1244.

Smoking Cessation in Mice Does Not Switch off Persistent Lung Inflammation and Does Not Restore the Expression of HDAC2 and SIRT1.

De Cunto G, Meo S, Bartalesi B, Cavarra E, Lungarella G, Lucattelli M Int J Mol Sci. 2022; 23(16).

PMID: 36012370 PMC: 9409159. DOI: 10.3390/ijms23169104.

More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM., and e-Cigarette Use.

Zhang Y, Wang L, Mutlu G, Cai H Front Physiol. 2021; 12:669152.

PMID: 34025456 PMC: 8131967. DOI: 10.3389/fphys.2021.669152.

References

Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

Willemse B, Lesman-Leegte I, Timens W, Postma D, Ten Hacken N . High cessation rates of cigarette smoking in subjects with and without COPD. Chest. 2005; 128(5):3685-7. DOI: 10.1378/chest.128.5.3685. View

Kohansal R, Martinez-Camblor P, Agusti A, Buist A, Mannino D, Soriano J . The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009; 180(1):3-10. DOI: 10.1164/rccm.200901-0047OC. View

Vestbo J, Hurd S, Agusti A, Jones P, Vogelmeier C, Anzueto A . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2012; 187(4):347-65. DOI: 10.1164/rccm.201204-0596PP. View

Hatayama O, Kobayashi T, Fujimoto K, Kubo K . Utility of single-slice high-resolution CT in upper lung field combined with low-dose spiral CT for lung-cancer screening in the detection of emphysema. Intern Med. 2007; 46(18):1519-25. DOI: 10.2169/internalmedicine.46.6343. View

Scanlon P, Connett J, Waller L, Altose M, Bailey W, Buist A . Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000; 161(2 Pt 1):381-90. DOI: 10.1164/ajrccm.161.2.9901044. View

Tashkin D, Rennard S, Hays J, Lawrence D, Marton J, Lee T . Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med. 2011; 105(11):1682-90. DOI: 10.1016/j.rmed.2011.04.016. View

Omori H, Fujimoto K, Katoh T . Computed-tomography findings of emphysema: correlation with spirometric values. Curr Opin Pulm Med. 2008; 14(2):110-4. DOI: 10.1097/MCP.0b013e3282f3f18f. View

Watson A, Joyce H, Hopper L, Pride N . Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men. Thorax. 1993; 48(2):119-24. PMC: 464285. DOI: 10.1136/thx.48.2.119. View

10.

Sansores R, Pare P, Abboud R . Effect of smoking cessation on pulmonary carbon monoxide diffusing capacity and capillary blood volume. Am Rev Respir Dis. 1992; 146(4):959-64. DOI: 10.1164/ajrccm/146.4.959. View

11.

Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W . Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med. 2006; 174(8):853-7. DOI: 10.1164/rccm.200603-422OC. View

12.

Vestbo J, Edwards L, Scanlon P, Yates J, Agusti A, Bakke P . Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365(13):1184-92. DOI: 10.1056/NEJMoa1105482. View

13.

McDonough J, Yuan R, Suzuki M, Seyednejad N, Elliott W, Sanchez P . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011; 365(17):1567-75. PMC: 3238466. DOI: 10.1056/NEJMoa1106955. View

14.

Willemse B, Postma D, Timens W, Ten Hacken N . The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004; 23(3):464-76. DOI: 10.1183/09031936.04.00012704. View

15.

Calverley P, Rabe K, Goehring U, Kristiansen S, Fabbri L, Martinez F . Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009; 374(9691):685-94. DOI: 10.1016/S0140-6736(09)61255-1. View

16.

Nakanishi M, Demura Y, Mizuno S, Ameshima S, Chiba Y, Miyamori I . Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation. Eur Respir J. 2006; 29(3):453-61. DOI: 10.1183/09031936.00015506. View

17.

KNUDSON R, Kaltenborn W, Burrows B . The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. Am Rev Respir Dis. 1989; 140(3):645-51. DOI: 10.1164/ajrccm/140.3.645. View

18.

Mohamed Hoesein F, de Hoop B, Zanen P, Gietema H, Kruitwagen C, van Ginneken B . CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax. 2011; 66(9):782-7. DOI: 10.1136/thx.2010.145995. View

19.

Tonnesen P, Carrozzi L, Fagerstrom K, Gratziou C, Jimenez-Ruiz C, Nardini S . Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007; 29(2):390-417. DOI: 10.1183/09031936.00060806. View

20.

Fletcher C, Peto R . The natural history of chronic airflow obstruction. Br Med J. 1977; 1(6077):1645-8. PMC: 1607732. DOI: 10.1136/bmj.1.6077.1645. View